Chemical inhibitors of OTTMUSG00000016327 can exert their effects through a variety of biochemical pathways, each influencing the function of the protein in a specific manner. Staurosporine, a well-known protein kinase inhibitor, blocks the kinase activity necessary for OTTMUSG00000016327 to function. Since kinase activity is central to the protein's role, staurosporine's inhibitory effect directly reduces OTTMUSG00000016327's ability to participate in its typical cellular processes. Similarly, JNK Inhibitor VIII and SP600125 target the c-Jun N-terminal kinases, which are integral to stress-activated protein kinase pathways involving OTTMUSG00000016327. The inhibition of these kinases by JNK Inhibitor VIII and SP600125 disrupts signaling cascades necessary for the optimal function of OTTMUSG00000016327, effectively decreasing its activity within the cell.
Furthermore, LY294002 and Wortmannin, both phosphoinositide 3-kinases (PI3K) inhibitors, undermine the PI3K pathway, which is crucial for the regulation and function of various proteins, including OTTMUSG00000016327. The interruption of this pathway by these inhibitors leads to a reduction in OTTMUSG00000016327 activity. MEK inhibitors like PD98059, U0126, and AZD6244 specifically target the MEK/ERK pathway, which is involved in the downstream signaling of OTTMUSG00000016327. By impeding this pathway, these inhibitors restrict the protein's ability to contribute to cellular signaling and functions. Rapamycin, targeting the mTOR pathway, inhibits a different aspect of the same signaling network as OTTMUSG00000016327, leading to its functional inhibition. Additionally, GF109203X, by inhibiting protein kinase C, affects signaling pathways that are essential for the activity of OTTMUSG00000016327, thereby reducing its functional capabilities. Lastly, BIRB 0796, another p38 MAP kinase inhibitor, disrupts the signaling pathways crucial for OTTMUSG00000016327's function, further contributing to the collective inhibition of this protein's activity within various cellular contexts. Each of these chemicals, by targeting specific kinases or pathways, ensures that the protein's activity is hindered, leading to its functional inhibition.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, which can inhibit OTTMUSG00000016327 by blocking kinase activity required for its function. | ||||||
JNK Inhibitor VIII | 894804-07-0 | sc-202673 | 5 mg | $272.00 | 2 | |
JNK Inhibitor VIII is specific to c-Jun N-terminal kinases, which are involved in stress-activated protein kinase pathways that OTTMUSG00000016327 is a part of; its inhibition would suppress OTTMUSG00000016327 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor; by inhibiting p38 MAP kinase, it disrupts the signaling pathways OTTMUSG00000016327 is involved in, leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor; PI3K pathway is crucial for many proteins, including OTTMUSG00000016327, and its inhibition can lead to functional inhibition of OTTMUSG00000016327. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor, which would inhibit the MEK/ERK pathway, a pathway in which OTTMUSG00000016327 operates, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which, by inhibiting PI3K, would also inhibit the activity of downstream proteins like OTTMUSG00000016327. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, and by inhibiting these, it would lead to inhibition of the MAPK/ERK pathway, thereby inhibiting OTTMUSG00000016327 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor; by inhibiting mTOR, which is a part of the same signaling pathway as OTTMUSG00000016327, it would lead to functional inhibition of OTTMUSG00000016327. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X is a protein kinase C inhibitor, which would inhibit signaling pathways involving protein kinase C that OTTMUSG00000016327 is part of, thus inhibiting its function. | ||||||
Doramapimod | 285983-48-4 | sc-300502 sc-300502A sc-300502B | 25 mg 50 mg 100 mg | $149.00 $281.00 $459.00 | 2 | |
BIRB 0796 inhibits p38 MAP kinase, and by doing so, it would disrupt the signaling pathways that are crucial for OTTMUSG00000016327's activity, leading to its inhibition. | ||||||